Datamonitor releases a new report – Celltrion Company Analysis

August 24, 2012 12:29 PM

Datamonitor is an international company providing market intelligence, data analysis and opinion via a worldwide network of in-house analysts. Datamonitor is a division of Informa plc, a United Kingdom-based publisher and conference company.

The company has released a new report, “Celltrion: Biosimilars Company Analysis” last  month.

This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development such as clinical trials for each key biosimilar molecule in development.

The company is thought to be responsible for filing the first biosimilar monoclonal antibody for approval in Europe. In 2009, Celltrion signed an agreement to manufacture and co-market eight biosimilars with Hospira in the US, EU and other key markets. And recently the company got the approval for the world’s first biosimilar monoclonal antibody in its homeland, South Korea.

If you want to buy the report, you can check the table of contents and rates from here:

 

Source: Wikipedia, Fast Market Research

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!